CD8A and neoplasm: Additionally, the release of TAAs (tumor-associated antigens) or TSAs (tumor-specific antigens) after tumor cell lysis and the antigen presentation by APCs (antigen-presenting cells) lead to an adaptive immune response and activation of antigen-specific CD4+ and CD8+ T cells.